Tirzepatide, the novel medication, is generating considerable interest within the healthcare community. It functions differently from traditional diabetes medications, targeting both receptors involved in blood regulation and satiety. Initial research have demonstrated impressive efficacy in controlling blood glucose in individuals with diabetes of